76 related articles for article (PubMed ID: 17105419)
1. The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer.
Pellegrini P; Berghella AM; Contasta I; Del Beato T; Adorno D
Cancer Biother Radiopharm; 2006 Oct; 21(5):443-67. PubMed ID: 17105419
[TBL] [Abstract][Full Text] [Related]
2. Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?
Berghella AM; Contasta I; Pellegrini P; Del Beato T; Adorno D
Cancer Biother Radiopharm; 2006 Oct; 21(5):468-87. PubMed ID: 17105420
[TBL] [Abstract][Full Text] [Related]
3. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
4. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
Contasta I; Berghella AM; Pellegrini P; Adorno D
Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
[TBL] [Abstract][Full Text] [Related]
5. Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network.
Contasta I; Berghella AM; Pellegrini P; Del Beato T; Casciani CA; Adorno D
Cancer Biother Radiopharm; 1999 Dec; 14(6):465-75. PubMed ID: 10850333
[TBL] [Abstract][Full Text] [Related]
6. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients.
Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D
Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345
[TBL] [Abstract][Full Text] [Related]
7. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
8. C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management.
Thirunavukarasu P; Sukumar S; Sathaiah M; Mahan M; Pragatheeshwar KD; Pingpank JF; Zeh H; Bartels CJ; Lee KK; Bartlett DL
J Natl Cancer Inst; 2011 Apr; 103(8):689-97. PubMed ID: 21421861
[TBL] [Abstract][Full Text] [Related]
9. Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy.
Contasta I; Pellegrini P; Berghella AM; Del Beato T; Adorno D
Cancer Biother Radiopharm; 2006 Oct; 21(5):488-505. PubMed ID: 17105421
[TBL] [Abstract][Full Text] [Related]
10. The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patients.
Sandler B; Smirnoff P; Shani A; Idelevich E; Kaganski N; Pfefferman R; Davidovich B; Zusman I
Anticancer Res; 1999; 19(5B):4229-33. PubMed ID: 10628379
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules.
Contasta I; Pellegrini P; Berghella AM; Adorno D
Cancer Biother Radiopharm; 2001 Feb; 16(1):63-71. PubMed ID: 11279799
[TBL] [Abstract][Full Text] [Related]
12. CEA as a prognostic factor in colorectal cancer.
Filella X; Molina R; Piqué JM; Grau JJ; Garcia-Valdecasas JC; Biete A; Novell F; Astudillo E; Bordas JM; Campo E
Anticancer Res; 1994; 14(2B):705-8. PubMed ID: 8010730
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum anti-p53 antibody measurement for colorectal cancer].
Kuwabara K; Kumamoto K; Ishibashi K; Ohsawa T; Kumagai Y; Baba H; Tsuji Y; Haga N; Ishida H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2167-9. PubMed ID: 23268012
[TBL] [Abstract][Full Text] [Related]
14. A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth.
Hou N; Zhang X; Zhao L; Zhao X; Li Z; Song T; Huang C
Biochem Biophys Res Commun; 2013 Oct; 439(4):471-6. PubMed ID: 24036270
[TBL] [Abstract][Full Text] [Related]
15. Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer.
Aldulaymi B; Christensen IJ; Sölétormos G; Jess P; Nielsen SE; Brünner N; Nielsen HJ
Anticancer Res; 2010 Jan; 30(1):233-7. PubMed ID: 20150641
[TBL] [Abstract][Full Text] [Related]
16. Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer.
Chao M; Gibbs P
J Clin Oncol; 2009 Dec; 27(36):e279-80; author reply e281. PubMed ID: 19901127
[No Abstract] [Full Text] [Related]
17. The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon cancer.
Kirat HT; Ozturk E; Lavery IC; Kiran RP
Am J Surg; 2012 Oct; 204(4):447-52. PubMed ID: 22481066
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
Albanopoulos K; Armakolas A; Konstadoulakis MM; Leandros E; Tsiompanou E; Katsaragakis S; Alexiou D; Androulakis G
Am J Gastroenterol; 2000 Apr; 95(4):1056-61. PubMed ID: 10763959
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
20. Cytokine expression in colon carcinoma.
Baier PK; Wolff-Vorbeck G; Eggstein S; Baumgartner U; Hopt UT
Anticancer Res; 2005; 25(3B):2135-9. PubMed ID: 16158955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
